Current Status
Price
Get Started
The hidden epidemic of diabetic kidney disease
Login/Register now to access the activity!
There is an urgent need to focus on screening programmes and implementation of appropriate therapy to detect kidney disease early and thereby prevent its progression. The unfortunate reality is that most chronic kidney disease (CKD) is asymptomatic until approximately 75% of kidney function is lost and, moreover, advanced CKD cannot be reversed. The current global trend towards an alarming increase in the prevalence of diabetes, especially type 2 diabetes mellitus (T2DM), has a direct impact on the prevalence of CKD. Approximately 40% of people living with T2DM and 30% of those with T1DM develop diabetic kidney disease (DKD).
Globally, DKD is the most common cause of CKD and 10% of patients with DKD will progress to kidney failure. Cardiovascular diseases (CVDs), including heart failure (HF) and atherosclerotic CVD (ASCVD), are the primary causes of mortality in patients with DKD (90%) on their path to kidney failure, underscoring the need for integrated management of diabetes, kidney and cardiovascular health. In this report, Professor Wearne shares her expertise with a concise and practical approach to evolving evidence-based management of DKD.
You will learn:
- How to diagnose and determine the prognosis of chronic kidney disease in the patient with diabetes
- The natural history and pathophysiology of diabetic kidney disease
- Current knowledge of the interrelationship between cardiovascular disease, kidney disease and diabetes, and approaches to risk management
- Evidence demonstrating cardiovascular and kidney protective effects of emerging type 2 diabetes therapies and guideline-recommended use of these medications.
Associate Professor Nicola Wearne
Groote Schuur Hospital
Cape Town
South Africa


